Solid Biosciences directors Koppel and Shah resign; shareholders approve doubling authorized shares to 120M

Solid Biosciences Inc.

Adam Koppel and Rajeev Shah resigned from the Board effective June 11, 2024; no disagreement cited.
Shareholders approved increase of authorized common stock from 60M to 120M shares.
Equity incentive plan amended to add 2M shares; total available for issuance increased accordingly.
Four Class III directors elected: Martin Freed, Ilan Ganot, Georgia Keresty, Ian Smith.
Advisory vote on executive compensation held every year; PricewaterhouseCoopers ratified as auditor for FY2024.

item 5.02 item 5.07 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Adam Koppel

Director

SLDB · Solid Biosciences Inc.

Effective: 2024-06-11
Filed: June 11, 2024, 7:59 PM ET

Adam Koppel notified Solid Biosciences Inc. (the “Company”) of his decision to resign as a member of the Company’s Board of Directors (the “Board”), effective as of June 11, 2024.

Departed

Rajeev Shah

Director

SLDB · Solid Biosciences Inc.

Effective: 2024-06-11
Filed: June 11, 2024, 7:59 PM ET

Rajeev Shah notified the Company of his decision to resign as a member of the Board, effective as of June 11, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Adam Koppel resigned as Director at Solid Biosciences Inc..

Action: resigned
Role: Director

Exact text from the filing

Adam Koppel notified Solid Biosciences Inc. (the “Company”) of his decision to resign as a member of the Company’s Board of Directors (the “Board”), effective as of June 11, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Rajeev Shah resigned as Director at Solid Biosciences Inc..

Action: resigned
Role: Director

Exact text from the filing

Rajeev Shah notified the Company of his decision to resign as a member of the Board, effective as of June 11, 2024.

View on SEC.gov

Solid Biosciences Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-159143

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.